Federal · Amendment

Two synthetic opioid analogues added to controlled-substances schedule with time-limited control periods

Controlled Substances Regulations — under the CONTROLLED DRUGS AND SUBSTANCES ACT

Recorded date: October 1, 2026
Detected: November 17, 2026. Verify commencement in the official source.

Health CareConsumer & Business

Plain-language summary · AI-assisted

Two substances — spirobrorphine and spirochlorphine — have been formally incorporated into the operative schedule of the Controlled Substances Regulations, each subject to control for a defined period. Previously listed as amendments not yet in force, these entries are now consolidated into the active text of the regulations. Any person or organization handling, researching, importing, or distributing these substances must treat them as controlled under the regulations for the specified window. Businesses and researchers working with novel synthetic compounds should review their licences and compliance programs to confirm these substances are covered.

Who this affects
pharmaceutical researchers and manufacturers · licensed dealers in controlled substances · importers and exporters of chemical substances · health-care facilities handling novel psychoactive substances · regulatory compliance officers in life sciences

Check the official text
SOR/2025-242 on the official source ↗

This page isn't an official version of the law and isn't legal advice. Summaries may omit details. Verify the dates and provisions that apply to you against the official source.

View this law's change history · Follow this law by RSS

Keep up with what changes.

The free weekly digest brings together published changes across our coverage. Confirm your email to subscribe.